These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 32685352)
1. The Lysosomal Diseases Testing Laboratory: A review of the past 47 years. Wenger DA; Luzi P JIMD Rep; 2020 Jul; 54(1):61-67. PubMed ID: 32685352 [TBL] [Abstract][Full Text] [Related]
3. Research update on lysosomal disorders with special emphasis on metachromatic leukodystrophy and Krabbe disease. Wenger DA APMIS Suppl; 1993; 40():81-7. PubMed ID: 8311994 [TBL] [Abstract][Full Text] [Related]
4. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases. Inui K; Wenger DA J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115 [TBL] [Abstract][Full Text] [Related]
5. Rare Diseases in Glycosphingolipid Metabolism. Zhou H; Wu Z; Wang Y; Wu Q; Hu M; Ma S; Zhou M; Sun Y; Yu B; Ye J; Jiang W; Fu Z; Gong Y Adv Exp Med Biol; 2022; 1372():189-213. PubMed ID: 35503182 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of patients with lysosomal storage disorders and peroxisomal disorders: A nationwide survey in Japan. Koto Y; Sakai N; Lee Y; Kakee N; Matsuda J; Tsuboi K; Shimozawa N; Okuyama T; Nakamura K; Narita A; Kobayashi H; Uehara R; Nakamura Y; Kato K; Eto Y Mol Genet Metab; 2021 Jul; 133(3):277-288. PubMed ID: 34090759 [TBL] [Abstract][Full Text] [Related]
8. Gene Therapy of Sphingolipid Metabolic Disorders. Shaimardanova AA; Solovyeva VV; Issa SS; Rizvanov AA Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835039 [TBL] [Abstract][Full Text] [Related]
9. Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry. Elliott S; Buroker N; Cournoyer JJ; Potier AM; Trometer JD; Elbin C; Schermer MJ; Kantola J; Boyce A; Turecek F; Gelb MH; Scott CR Mol Genet Metab; 2016 Aug; 118(4):304-9. PubMed ID: 27238910 [TBL] [Abstract][Full Text] [Related]
10. Leukodystrophies underlying cryptic spastic paraparesis: frequency and phenotype in 76 patients. Müller vom Hagen J; Karle KN; Schüle R; Krägeloh-Mann I; Schöls L Eur J Neurol; 2014 Jul; 21(7):983-8. PubMed ID: 24698313 [TBL] [Abstract][Full Text] [Related]
11. [Recent advances in the diagnosis and treatment of lysosomal storage diseases]. Wu XR; Bao XH Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):440-4. PubMed ID: 16086072 [TBL] [Abstract][Full Text] [Related]
12. Death rates in the U.S. due to Krabbe disease and related leukodystrophy and lysosomal storage diseases. Barczykowski AL; Foss AH; Duffner PK; Yan L; Carter RL Am J Med Genet A; 2012 Nov; 158A(11):2835-42. PubMed ID: 22991292 [TBL] [Abstract][Full Text] [Related]
13. Lyso-glycosphingolipids: presence and consequences. van Eijk M; Ferraz MJ; Boot RG; Aerts JMFG Essays Biochem; 2020 Sep; 64(3):565-578. PubMed ID: 32808655 [TBL] [Abstract][Full Text] [Related]
14. Newborn screening for lysosomal storage disorders. Nakamura K; Hattori K; Endo F Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):63-71. PubMed ID: 21312327 [TBL] [Abstract][Full Text] [Related]